These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9399969)

  • 21. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
    Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.
    Gale JD; Grossman CJ; Whitehead JW; Oxford AW; Bunce KT; Humphrey PP
    Br J Pharmacol; 1994 Jan; 111(1):332-8. PubMed ID: 8012715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
    Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
    Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in vitro pharmacology and non-clinical cardiovascular safety studies of a novel 5-HT
    Tsubouchi T; Kunimatsu T; Tsujimoto S; Kiyoshi A; Katsura Y; Oku S; Chihara K; Mine Y; Yamada T; Shimizu I; Bando K
    Eur J Pharmacol; 2018 May; 826():96-105. PubMed ID: 29501863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
    Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
    Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 5-HT(4)-receptor activation-induced neural plasticity enhances in vivo reconstructs of enteric nerve circuit insult.
    Matsuyoshi H; Kuniyasu H; Okumura M; Misawa H; Katsui R; Zhang GX; Obata K; Takaki M
    Neurogastroenterol Motil; 2010 Jul; 22(7):806-13, e226. PubMed ID: 20146727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles.
    Kii Y; Ito T
    J Cardiovasc Pharmacol; 1997 May; 29(5):670-5. PubMed ID: 9213211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of the 5-HT4 receptor in the intestinal tract and striatum of the guinea pig.
    Uchiyama-Tsuyuki Y; Saitoh M; Muramatsu M
    Life Sci; 1996; 59(25-26):2129-37. PubMed ID: 8950316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients.
    Liu Z; Sakakibara R; Odaka T; Uchiyama T; Uchiyama T; Yamamoto T; Ito T; Asahina M; Yamaguchi K; Yamaguchi T; Hattori T
    Mov Disord; 2005 Jun; 20(6):680-6. PubMed ID: 15719424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors.
    Taniyama K; Nakayama S; Takeda K; Matsuyama S; Shirakawa J; Sano I; Tanaka C
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1098-104. PubMed ID: 1890614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo.
    Crema F; Modini C; Croci T; Langlois M; de Ponti F
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1045-52. PubMed ID: 10027842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
    Kanazawa M; Watanabe S; Tana C; Komuro H; Aoki M; Fukudo S
    Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
    Yamano M; Kamato T; Miyata K
    Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of SK-951, a novel benzofuran derivative, as an agonist to 5-HT4 receptors.
    Takeda M; Tsukamoto K; Mizutani Y; Suzuki T; Taniyama K
    Jpn J Pharmacol; 1999 Feb; 79(2):203-12. PubMed ID: 10202856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
    Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M
    J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergy between 5-HT4 receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach.
    Cellek S; Thangiah R; Jarvie EM; Vivekanandan S; Lalude O; Sanger GJ
    Neurogastroenterol Motil; 2008 May; 20(5):539-45. PubMed ID: 18194150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists.
    Leung E; Pulido-Rios MT; Bonhaus DW; Pekins LA; Zeitung KD; Hsu SA; Clark RD; Wong EH; Eglen RM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):145-56. PubMed ID: 8857591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of a novel 5-HT4 receptor agonist, TS-951, in vitro.
    Kajita S; Ito C; Kawamura R; Yasuda S; Isobe Y; Fukushima K
    Pharmacology; 2001 Jul; 63(1):8-16. PubMed ID: 11408827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cisapride, a gastroprokinetic agent, binds to 5-HT4 receptors].
    Katayama K; Morio Y; Haga K; Fukuda T
    Nihon Yakurigaku Zasshi; 1995 Jun; 105(6):461-8. PubMed ID: 7557734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.